4169 Coronavirus spike protein receptor-binding domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 50 | 10.0 | 4.99× | q < 0.0001 | |
| Lipids and lipid-like molecules | 4 | 5.6 | 0.71× | q = 0.73 | |
| Homogeneous non-metal compounds | 4 | 10.8 | 0.37× | q = 0.03 | |
| Organic acids and derivatives | 1 | 7.8 | 0.13× | q = 0.01 | |
| Organoheterocyclic compounds | 1 | 7.7 | 0.13× | q = 0.01 | |
| Homogeneous metal compounds | 2 | 24.7 | 0.08× | q < 0.0001 | |
| Nucleosides, nucleotides, and analogues | 0 | 13.9 | 0 | q < 0.0001 | |
| Organosulfur compounds | 1 | 1.0 | 0.97× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 1,452 |
| DB14104 | EIC | Linoleic acid | 72 |
| DB04224 | ELA | Oleic Acid | 6 |
| DB00755 | REA | Tretinoin | 3 |
| DB03193 | STE | Stearic acid | 3 |
| DB03796 | PLM | Palmitic Acid | 3 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB00172 | PRO | Proline | 2 |
| DB03740 | NDG | N-acetyl-alpha-D-glucosamine | 2 |
| DB04473 | FUC | alpha-L-fucose | 2 |
| DB03175 | POL | Propyl alcohol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 3,041 |
| EIC | LINOLEIC ACID | 102 |
| CL | CHLORIDE ION | 34 |
| 8Z9 | Sapienic acid | 19 |
| PLM | PALMITIC ACID | 9 |
| STE | STEARIC ACID | 9 |
| KZ0 | 2,4,6-tris(chloromethyl)-1,3,5-triazine | 7 |
| ELA | Elaidic acid | 6 |
| IDU | 2-O-sulfo-beta-L-altropyranuronic acid | 3 |
| NAmetal | SODIUM ION | 3 |
| OLA | OLEIC ACID | 3 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 3 |
| PRO | PROLINE | 3 |
| Q83 | 7-(6-nitro-2,3-dihydroindol-1-yl)-7-oxidanylidene-heptanoic acid | 3 |
| REA | RETINOIC ACID | 3 |
| VCG | 2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-6-O-(2-{[(9E)-octadec-9-enoyl]oxy}ethyl)-alpha-L-xylo-hexofuranoside | 3 |
| MGmetal | MAGNESIUM ION | 2 |
| NDG | 2-acetamido-2-deoxy-alpha-D-glucopyranose | 2 |
| P4G | 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE | 2 |
| XIO | [(2~{S})-2-[[4-(2-azanylethanoylamino)-7-[[(2~{S})-3-[2-(4-nitrophenyl)sulfanyl-1~{H}-indol-3-yl]-1-oxidanylidene-1-sodiooxy-propan-2-yl]amino]-4-[3-[[(2~{S})-3-[2-(4-nitrophenyl)sulfanyl-1~{H}-indol-3-yl]-1-oxidanylidene-1-sodiooxy-propan-2-yl]amino]-3-oxidanylidene-propyl]-7-oxidanylidene-heptanoyl]amino]-3-[2-(4-nitrophenyl)sulfanyl-1~{H}-indol-3-yl]propanoyl]oxysodium | 2 |